These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2363121)

  • 1. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
    Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy.
    Brill-Edwards P; Van Ryn-McKenna J; Cai L; Ofosu FA; Buchanan MR
    Thromb Haemost; 1992 Oct; 68(4):424-7. PubMed ID: 1448774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E; Watton J; Cesmeli S; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1991 Apr; 65(4):355-9. PubMed ID: 2057916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.
    Peters RF; Lees CM; Mitchell KA; Tweed MF; Talbot MD; Wallis RB
    Thromb Haemost; 1991 Mar; 65(3):268-74. PubMed ID: 1710836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reocclusion after thrombolysis: a problem solved by hirudin?
    Rübsamen K; Eschenfelder V
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of recombinant desulphatohirudin on arterial thrombosis in rats.
    Talbot MD; Ambler J; Butler KD; Lees CM; Mitchell KA; Peters RF; Tweed MF; Wallis RB
    Haemostasis; 1991; 21 Suppl 1():73-9. PubMed ID: 1654294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
    Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
    Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
    Van Ryn-McKenna J; Merk H; Müller TH; Buchanan MR; Eisert WG
    Thromb Haemost; 1993 Mar; 69(3):227-30. PubMed ID: 8470045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis.
    Fioravanti C; Burkholder D; Francis B; Siegl PK; Gibson RE
    Thromb Res; 1993 Aug; 71(4):317-24. PubMed ID: 8236160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis.
    Kaiser B; Simon A; Markwardt F
    Thromb Haemost; 1990 Feb; 63(1):44-7. PubMed ID: 2140204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.